Compare ADMA Biologics Inc (ADMA) vs Beyond Meat Inc (BYND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Beyond Meat Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Beyond Meat Inc trades at $0.42 (market cap $215.41M). The key difference: ADMA Biologics Inc is far larger — about 10.3× Beyond Meat Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Beyond Meat Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BYND | |
|---|---|---|
Market Cap | $2.22B | $215.41M |
Sector | Health | Consumer Staples |
52-Week High | $20.38 | $3.62 |
52-Week Low | $7.60 | $0.42 |
Enterprise Value | $2.29B | $455.69M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Beyond Meat Inc
Beyond Meat is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat, is targeted to omnivores and vegetarians alike, and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food-service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to nearly 50% in time.
Read more on BYND →
